Sodium Thiopental

Thiopentanal (Tiopentan) Sodium and its administration **Thiopentanal** is a synthetic benzodiazepine-type drug that is used as a drug preparation and for inhalational general anesthesia. This drug was originally developed in the UK by UCL Laboratories in 1932, while the practical use of this narcotic drug was due to the Earl of Hare, who used Thiopentanal in his clinical practice back in 1894. This anesthetic has been used intravenously by injection to prescribe inhalation zones of anesthetic devices in medical practice for the past more than a year.

The half-life of Thiopentane is approximately 16-20 hours in the adult human body. It is widely used for long and complex procedures in traumatology, cardiology, and surgery. Thiopenatane may also be used for anesthetic purposes prior to general anesthesia, as well as for other narcotic purposes in the treatment of schizophrenia.

The following are the main disadvantages of Thiopentene. Among them are contraindications to the use of the drug in the presence of hypersensitivity to the drug; subject to bronchial asthma, respiratory tract diseases, allergic reactions in the ken area, somatic diseases in the form of impaired myocardial contraction, decreased hemoglobin, and respiratory failure. The most serious complication of taking Thiobenal is the risk of fatal bleeding and cardiac arrest. The incoming drug should not be taken by patients with a severe degree of sleep disturbance, migraine, epistasis, problems with the removal of lactic acid from the body, a high degree of blood intoxication, acute disease of the gastrointestinal tract, heart failure, cranial trauma, and pregnant women. The drug is ineffective for patients with infectious diseases, elderly people, and for use in severe, advanced cases of the disease.